Many projects have been done with out M-Det-56 proof-of-concept platform. Here we present some of these results to demonstrate the power of M-DET approach for differential diagnosis of breast and ovarian cancers.
Obviously, the more fragments we test to find those few that will be the best for a specific task, the better will be the results. Here we show (image in the next section) the difference between Proof-of-Concept M-Det-56 and M-Det-244k platforms.
Imagine how much better will be the results for your project!
An example of Proof-of-Concept results for differential diagnosis of breast and ovarian cancers (here the Proof-of Concept M-DET-56 was used to select informative fragments):
Healthy vs. DCIS 80% 88%
Healthy vs. IDC 87% 85%
IDC vs. DCIS 87% 76%
Healthy vs. OvCa 89% 79%
Healthy vs. Benign 74% 78%
Benign vs. OvCa 82% 71%
Increasing the number of tested sites from 56 to 244,000 allows us to: